India's GlaxoSmithKline Pharmaceuticals reported a higher adjusted third-quarter profit on Friday, led by sustained demand for its respiratory drugs and antibiotic Augmentin.

India's Glenmark Pharmaceuticals reported third-quarter profit below estimates on Friday due to bleak U.S. demand for its long-term illness drugs.

India's pharmaceutical industry is poised for significant growth, with its share in the global market expected to rise to 5 ...

The global pharmaceutical industry is valued at approximately $1.6 trillion, while India's market stands at $55 billion, ...

Elara sees the ongoing weakness as an opportunity to buy into the pharma space, as it expects robust earnings growth ahead at ...

Aside from reciprocal tariffs, US President Trump has teased imposing tariffs on several import heavy sectors, including ...

The Nifty Pharma Index has taken a hit, dropping nearly 2% in Friday’s trade. Over the last five days, the index has declined by approximately 4.3%, and on a year-to-date basis, it has fallen by ...

One might think that a pharmaceutical ingredients company that boasts clients in 80 countries, certification from several ...

Indian pharma exporters must unite and report challenges in exports to overcome trade barriers: Raja Bhanu: Shardul Nautiyal, Mumbai Friday, February 14, 2025, 08:00 Hrs [IST] The ...

India’s rapid digitalization and youthful population position it for long-term economic expansion, with its internet economy ...

The implementation of the revised Schedule M marks a critical step towards enhancing the quality and safety of pharmaceutical ...

The TRUST initiative follows India’s induction into the US-led Minerals Security Finance Network in September last year and ...